Compound information
- Natural Products
- ZC441136
- Molecular Formula
- C12H16NO7P
- Molecular Weight
- 317.066438482 g/mol
- Structure
-
- IUPAC Name
- (2S)-2-(benzyloxycarbonylamino)-2-dimethoxyphosphoryl-acetic acid
- InChI
- InChI=1S/C12H16NO7P/c1-18-21(17,19-2)10(11(14)15)13-12(16)20-8-9-6-4-3-5-7-9/h3-7,10H,8H2,1-2H3,(H,13,16)(H,14,15)/t10-/m0/s1
- InChI Key
- RTXDKVFNAOMDFV-JTQLQIEISA-N
- SMILES
- COP(=O)(OC)[C@H](NC(=O)OCc1ccccc1)C(=O)O
- Source
- ZINC000097757461
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 21 | Ring Count | 1 |
Heteroatom Count | 9 | Rotatable Bond Count | 7 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 111.16 Å2 | LogP | 0.73 |
LogS | -2.11 | LogD | -0.534 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.001 | Pgp substrate | 0.001 |
HIA | 0.338 | F20 % | 0.969 |
F30 % | 0.055 | Caco-2 | -6.155 |
MDCK | -5.416 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.212 | PPB | 79.858 |
VD | 0.422 | Fu | 0.629 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.614 |
CYP2A6 substrate | 0.474 | CYP2B6 substrate | 0.553 |
CYP2C19 inhibitor | 0.039 | CYP2C19 substrate | 0.852 |
CYP2C8 substrate | 0.709 | CYP2C9 inhibitor | 0.014 |
CYP2C9 substrate | 0.992 | CYP2D6 inhibitor | 0.002 |
CYP2D6 substrate | 0.254 | CYP2E1 substrate | 0.482 |
CYP3A4 inhibitor | 0.004 | CYP3A4 substrate | 0.274 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.717 | CL | 3.249 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.012 | Hepatotoxicity | 0.61 |
Mutagenicity | 0.616 | Rat Oral Acute Toxicity | 0.065 |
FDAMDD | 0.058 | Skin Sensitization | 0.021 |
Carcinogenicity | 0.003 | Eye Corrosion | 0.002 |
Eye Irritation | 0.054 | Respiratory Toxicity | 0.042 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.001 | IGC50 | 1.687 |
LC50FM | 2.752 | LC50DM | 6.055 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.283 | NR-AR-LBD | 0.3 |
NR-AhR | 0.013 | NR-Aromatase | 0.029 |
NR-ER | 0.328 | NR-ER-LBD | 0.422 |
NR-PPAR-gamma | 0.447 | SR-ARE | 0.149 |
SR-ATAD5 | 0.29 | SR-HSE | 0.02 |
SR-MMP | 0.012 | SR-p53 | 0.024 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.